Clark’s stock continued for a second day and raised the prospect that an activist investor could surface and try to block its merger-of-equals deal with Tylenol maker Kenvue.

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.

Texas-based Kimberly-Clark Corp. will acquire Kenvue Inc., the New Jersey-based manufacturer of Tylenol, the companies ...

Kimberly-Clark announced it will acquire Summit-based Kenvue in a cash and stock transaction valued at $48.7 billion. The ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark Corporation , a global personal care leader, and Kenvue Inc. , a global consumer health leader, today announced an agreement under which Kimberly-Clark will acquire all of the ...

The deal is expected to close in the second half of next year. Kimberly-Clark, which owns Huggies and Kleenex, is acquiring Kenvue, the maker of Tylenol, in a cash and stock deal worth about $48.7 ...